MOTS-C
Last updated: January 23, 2026
For informational purposes only. Not medical advice. Always consult a healthcare professional.
Tried MOTS-C? Be part of the collective knowledge. Share your experience - your insights help others on their journey.
What Is MOTS-C?
MOTS-c (Mitochondrial ORF of the 12S rRNA Type-C) is a 16-amino acid peptide encoded by mitochondrial DNA that acts as a retrograde signaling molecule from mitochondria to the nucleus. It regulates cellular metabolism primarily through AMPK pathway activation, improving glucose metabolism, reducing insulin resistance, enhancing exercise capacity, and promoting metabolic homeostasis across multiple tissues.
Quick Verdict
An exercise mimetic. That phrase alone explains why MOTS-c has attracted attention. This mitochondrial-derived peptide activates AMPK and improves metabolic markers in early data. The science is genuinely exciting. But “early” is doing heavy lifting in that sentence. No large RCTs exist, the community is small, and the compound requires subcutaneous injection. Sentiment is 78/100 across 8 tracked studies.
Evidence Quality
- Human trials: Weak (early-phase studies showing metabolic improvements; no large RCTs)
- Animal evidence: Moderate (exercise mimetic effects in mice are reproducible)
- Community reports: Sparse (small user base, mostly in dedicated biohacking circles)
- Key uncertainty: Whether injecting a peptide that mimics exercise actually produces the same downstream tissue adaptations as actual exercise, or just the metabolic markers.
What the Research Shows
MOTS-c requires subcutaneous injection, which limits its audience to those already familiar with peptide protocols. Research shows MOTS-c treatment significantly improved insulin sensitivity, reduced obesity, and enhanced exercise capacity in animal models. The appeal is metabolic benefits for those who cannot exercise due to injury, disability, or severe deconditioning. For healthy individuals who can exercise, the value proposition over actual exercise is unclear and probably unfavorable based on current evidence. This belongs on a watchlist, not in a daily protocol, for most purposes.
Who Should Be Cautious
Anyone with insulin-dependent diabetes should be cautious with AMPK activators due to potential hypoglycemic effects. Pregnant or nursing individuals have zero safety data.
What This Page Cannot Tell You
Optimal dose, frequency, and duration of MOTS-c protocols in humans are unknown. Everything being used right now is experimental, and “experimental” means nobody knows the right answer yet.
What Experts Say
My favorite mitochondrial optimizers: Creatine, NMN, CoQ10, ALA, PQQ, L-Carnitine, TMG, Magnesium, NAC, B vitamins, Metformin, Oxaloacetate, Methylene Blue, SS-31, MOTS-c
BPC-157 – repairs corrupted repair pathways. MOTS-c – rewrites mitochondrial energy output. SS-31 – patches electron transport chain leakage. Reta – executes the metabolic override. TB-500 – deploys systemic recovery
5 months 11 days - Reta 6mg/wk, GLOW 2.5mg/day, Ipamorelin/cjc .175mg each/night, KPV .3mg/night, MotsC .8mg/day, MT-2 .25mg/day load -> .25mg/wk
Quotes sourced from public posts on X or contributed exclusively to Dopamine Club. Views expressed are those of the original authors.
MOTS-C Research & Studies
01 The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance ▸
MOTS-c treatment significantly improved insulin sensitivity, reduced obesity, and enhanced metabolic homeostasis in animal models through AMPK activation and improved glucose metabolism.
View Study (PubMed)02 The role of MOTS-c-mediated antioxidant defense in aerobic exercise alleviating diabetic myocardial injury ▸
MOTS-c treatment (0.5 mg/kg/day) reduced myocardial damage in diabetic rats by enhancing antioxidant defenses through Keap1/Nrf2 pathway activation and improved cardiac function comparable to aerobic exercise.
View Study (PubMed)03 The mitochondrial signaling peptide MOTS-c improves myocardial performance during exercise training in rats ▸
MOTS-c enhanced cardiac systolic function and mechanical efficiency in exercised rats, demonstrating synergistic effects with aerobic training on cardiovascular performance.
View Study (PubMed)04 MOTS-c Functionally Prevents Metabolic Disorders ▸
Review confirms MOTS-c reduces insulin resistance, prevents obesity, improves muscle function, promotes bone metabolism, and enhances immune regulation primarily through AICAR-AMPK signaling pathway activation.
View Study (PubMed)05 MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation ▸
Comprehensive review demonstrating MOTS-c's benefits for diabetes, obesity, aging, and cardiovascular disease, with plasma levels decreasing with age and tissue-specific expression patterns.
View Study (PubMed)06 The mitochondrial-derived peptide MOTS-c relieves hyperglycemia and insulin resistance in gestational diabetes mellitus ▸
MOTS-c treatment effectively reduced blood glucose levels and improved insulin sensitivity in gestational diabetes models, showing therapeutic potential for pregnancy-related metabolic dysfunction.
View Study (PubMed)07 MOTS-c modulates skeletal muscle function by directly binding and activating CK2 ▸
Research identified CK2 as a direct binding target of MOTS-c, revealing a novel mechanism for its effects on skeletal muscle function beyond AMPK activation.
View Study (PubMed)08 The intraperitoneal administration of MOTS-c produces antinociceptive and anti-inflammatory effects through the activation of AMPK pathway in the mouse formalin test ▸
MOTS-c demonstrated pain-reducing and anti-inflammatory properties through AMPK pathway activation in animal pain models, suggesting potential therapeutic applications beyond metabolic effects.
View Study (PubMed)MOTS-C User Reviews & Experiences
Sentiment score computed from aggregated public user reports, forums, and community discussions. Not a clinical measure.
Users consistently report significant energy improvements, enhanced exercise capacity, and effective weight loss support when combined with GLP-1 agonists. Most describe it as a 'game changer' with notable effects on metabolism and recovery, though a minority report no benefits, possibly due to already good metabolic health or product quality issues.
MOTS-C Benefits, Dosage & Side Effects
- Clean Energy Boost: Users report sustained energy increases without stimulant-like effects, particularly noticeable as part of morning or pre-workout protocols
- Enhanced Exercise Performance: Improved endurance, faster recovery, and better workout capacity consistently reported, with some users noting it amplifies training benefits
- Metabolic Support: Significant improvements in weight loss and body composition when combined with diet or GLP-1 medications, with users overcoming typical winter weight gain patterns
- Reduced Fatigue on GLP-1s: Multiple users report MOTS-c counteracts the lethargy commonly experienced with semaglutide or tirzepatide treatment
- Exercise Mimetic Properties: Functions as a partial exercise substitute, with research and users confirming it replicates some metabolic benefits of physical training
- Synergistic Effects: Works particularly well when combined with actual exercise or GLP-1 agonists, with enhanced results compared to monotherapy
- Individual Variability: Those with poor metabolic health report dramatic benefits, while metabolically healthy individuals may experience minimal effects
- Cumulative Benefits: Effects appear to build over weeks rather than being immediately noticeable, with optimal results after consistent 4-8 week use
- Standard Protocol: 2-5mg administered 2-3 times weekly (total 4-15mg/week) is most commonly reported, often split into subcutaneous injections
- Daily Microdosing: Some users report success with 500mcg-2mg daily, particularly when using it as pre-workout or morning energy support
- High-Dose Approaches: A subset uses 5-10mg daily, though this appears less common and may be excessive based on research using 0.5mg/kg in animals
- Timing Considerations: Morning and pre-workout administration most popular, with some users avoiding evening doses due to energy-boosting effects
- Rapid Heart Rate: Small number of users report increased heart rate or palpitations, particularly at higher doses or when first starting
- Individual Sensitivity: Rare reports of severe reactions including shock-like symptoms, though these appear to be outliers and may relate to product quality
- Interaction Concerns: Some sources suggest caution when combining with GLP-1 agonists, though many users successfully stack them without issues
- Minimal Side Effects: Majority of users report no negative effects, describing it as one of the safest peptides with primarily positive outcomes
- Research Peptide Market: Widely available from peptide research sources, though quality varies significantly between sources
- Injectable Form Preferred: Most users administer via subcutaneous injection, as oral bioavailability appears poor based on user reports
- Cost Considerations: Generally affordable compared to other peptides, with typical monthly costs ranging $50-150 depending on dosage and source
Related Compounds
Community Reviews
Share your experience with MOTS-C and help others make informed decisions.
Write a Review
Sign in to leave a review